Pulmicort instruction update
Executive Summary
AstraZeneca will post updated patient instructions on their Pulmicort Flexhaler (budesonide inhalation powder) Web site and send patient instruction tear sheets to pharmacies as soon as FDA approves the changes, according to an Institute for Safe Medication Practices alert. The current product label does not clearly explain that the dose-counter is labeled in increments of 20, which makes determining the specific number of remaining doses difficult for patients...